Calian Group (TSE:CGY – Get Free Report) had its target price raised by Canaccord Genuity Group from C$103.00 to C$105.00 in a report issued on Monday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 22.32% from the stock’s current price.
A number of other analysts have also commented on CGY. Stifel Nicolaus set a C$100.00 target price on shares of Calian Group and gave the stock a “buy” rating in a report on Wednesday, May 20th. Royal Bank Of Canada increased their price target on Calian Group from C$78.00 to C$90.00 and gave the company an “outperform” rating in a research note on Friday, May 15th. ATB Cormark Capital Markets raised their price target on Calian Group from C$92.50 to C$98.50 and gave the stock an “outperform” rating in a research report on Tuesday, May 19th. Ventum Financial lifted their price objective on Calian Group from C$84.00 to C$94.00 and gave the stock a “buy” rating in a research note on Tuesday, March 10th. Finally, Canadian Imperial Bank of Commerce upped their price objective on Calian Group from C$76.00 to C$90.00 in a report on Friday, May 15th. Nine analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Calian Group presently has an average rating of “Buy” and a consensus target price of C$92.06.
View Our Latest Analysis on CGY
Calian Group Trading Up 1.0%
Calian Group (TSE:CGY – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported C$1.30 EPS for the quarter. The company had revenue of C$228.70 million during the quarter. Calian Group had a net margin of 3.97% and a return on equity of 10.35%. On average, analysts predict that Calian Group will post 4.9475219 earnings per share for the current year.
Insiders Place Their Bets
In other news, insider Patrick Belanger Houston sold 6,432 shares of the company’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of C$80.91, for a total transaction of C$520,413.12. Following the completion of the transaction, the insider directly owned 22,266 shares of the company’s stock, valued at C$1,801,542.06. This represents a 22.41% decrease in their ownership of the stock. Insiders own 0.63% of the company’s stock.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Further Reading
- Five stocks we like better than Calian Group
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
